Technical Data

S9505-01A
Clone Type
Polyclonal
Host
Rabbit
Source
Human
Isotype
IgG
Applications
IHC WB
Crossreactivity
Hu Rt
Shipping Temp
Blue Ice
Storage Temp
-20°C
Rabbit Anti-Synuclein, pan (Alpha Synuclein, Beta Synuclein, Breast Cancer Specific Gene 1 Protein, Breast Cancer-specific Gene 1 Protein, BCSG1, Gamma Synuclein, Gamma-synuclein, Non-A beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, PARK1, Persyn, PRSN, Synuclein alpha, SNCA, Synuclein beta, SNCB, Synuclein gamma, SNCG, Synoretin, SR)

Alpha synuclein is an abundant 140 amino acid neuronal protein, expressed primarily at presynaptic terminals in the central nervous system. Alpha synuclein has been associated with several neurodegenerative diseases. A point mutation in the gene coding for the alpha-synuclein protein was the first discovery linking this protein to a rare familial form of Parkinson's disease (PD). Subsequently, other mutations in the alpha-synuclein gene have been identified in familial PD. The aggregated proteinaceous inclusions called Lewy bodies found in PD and cortical Lewy body dementia (LBD) were discovered to be predominantly alpha-synuclein. Aberrant aggregation of alpha-synuclein has been detected in an increasing number of neurodegenerative diseases, collectively known as synucleopathies. Alpha-synuclein exists physiologically in both soluble and membrane-bound states, in unstructured and alpha-helical conformations, respectively. The physiological function of alpha-synuclein appears to require its translocation between these subcellular compartments and interconversion between the 2 conformations. Abnormal processing of alpha-synuclein is predicted to lead to pathological changes in its binding properties and function (1).

Applications
Suitable for use in Western Blot and Immunohistochemistry. Other applications not tested.
Recommended Dilution
Optimal dilutions to be determined by the researcher.
Storage and Stability
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, add sterile glycerol (40-50%), aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Immunogen
A synthetic peptide (AKEGVVAAAEKTKQGV) as a consensus part of human alpha-, beta-, and gamma synuclein proteins conjugated to diphteria toxoid.
Form
Supplied as a lyophilized powder. Reconstitute in 100ul of sterile water. Centrifuge to remove any insoluble material.
Purity
As reported
Specificity
Overlap specific immunohistochemical staining of alpha-, beta- and gamma synucleins Species Crossreactivity: This antiserum recognizes human and rat alpha-, beta- and gamma synucleins.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

References
1. Lundvig, et al Brain Res Mol Brain Res 134, 3-17 (Mar 24, 2005). ; 2. Bennett, Pharmacol Ther 105, 311-31 (Mar, 2005). ; 3. Vekrellis, et al., Mol Neurobiol 30, 1-21 (Aug, 2004). ; 4. Martin, et al., Protein Pept Lett 11, 229-37 (Jun, 2004). ; 5. Doherty, et al., Acta Neuropathol (Berl) 107, 169-75 (Feb, 2004). ; 6. Goedert, Curr Opin Genet Dev 11, 343-51 (Jun, 2001). ; 7. Saito, et al., J Neurol Sci 177, 48-59 (Aug 1, 2000). ; 8. Lucking, et al., Cell Mol Life Sci 57, 1894-908 (Dec, 2000). ; 9. Kahle, et al., Ann N Y Acad Sci 920, 33-41 (2000). ; 10. Clayton, et al., Trends Neurosci 21, 249-54 (Jun, 1998).
USBio References
No references available
United States Biological | 4 Technology Way | Salem, MA 01970
Phone 800-520-3011 | Fax 978-594-8052 | Website www.usbio.net